Strategic positioning: in this setting, GLP-1RAs are best positioned as adjunct metabolic optimization to improve the response to standard OI, rather than as substitutes for OI
This dose escalation schedule means that you may not experience the full therapeutic effects until you reach the maintenance dose
Key points Key messages from the paper Incretin analogues (semaglutide, tirzepatide) provide effective glucose control in type 2 diabetes mellitus (T2DM) and major weight losses in people without diabetes
Difference in gastrointestinal risk associated with use of GLP-1 receptor agonists: A real-world pharmacovigilance study
How to Support Your Skin While Losing Weight Some of the best protection is built into how you lose the weight in the first place: Aim for steady, gradual loss rather than crash dieting, so skin has time to adapt
Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimers and Parkinsons diseases
